These findings point at a possible role for syndecan-3 in cancer stem cells, or tumor-initiating cells, which are discussed to represent a cell pool characterized by increased resistance to conventional therapies due to the expression of multidrug resistance proteins, increased DNA repair capacity, high developmental plasticity, and unlimited proliferation [50]. Here, SDC3 is linked to neoplasm.